• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Reichow Gregory was granted 22,543 shares (SEC Form 4)

    6/13/25 7:44:15 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ENVX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Reichow Gregory

    (Last) (First) (Middle)
    C/O ENOVIX CORPORATION
    3501 W. WARREN AVENUE

    (Street)
    FREMONT CA 94538

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Enovix Corp [ ENVX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/12/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/12/2025 A 22,543(1) A $0 58,281(2) D(3)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 12, 2025, December 12, 2025, March 12, 2026 and the earlier of (i) June 12, 2026; or (ii) the date of the Issuer's 2026 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.
    2. Includes 26,325 shares issuable upon the settlement of RSUs granted to the Reporting Person.
    3. Pursuant to the Eclipse GP III, LLC Agreement, the Reporting Person is deemed to hold the RSUs for the benefit of Eclipse Ventures, LLC ("Eclipse"), which is entitled to hold the shares upon settlement of the RSUs. Eclipse may be deemed the indirect beneficial owner of such shares, and the Reporting Person is a partner of and may be deemed to share voting and dispositive power over shares held by Eclipse. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
    Remarks:
    /s/ Arthi Chakravarthy, Attorney-in-Fact for Gregory Reichow 06/13/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ENVX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENVX

    DatePrice TargetRatingAnalyst
    10/31/2024Buy → Neutral
    Janney
    7/22/2024$25.00Buy
    The Benchmark Company
    12/18/2023Outperform
    William Blair
    7/21/2023$19.00 → $20.00Outperform → Market Perform
    TD Cowen
    1/11/2023$20.00Buy
    Canaccord Genuity
    12/2/2022$19.00Buy
    B. Riley Securities
    11/4/2022$23.00Buy
    Janney
    9/28/2022$25.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $ENVX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enovix Announces First Quarter 2025 Financial Results

      FREMONT, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation ("Enovix") (NASDAQ:ENVX), a global high-performance battery company, announced today financial results for the first quarter 2025, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the first quarter of 2025, Enovix advanced across critical milestones with our lead smartphone customer, keeping us on track for a customer product launch later this year. We also strengthened our leadership team, expanded our manufacturing footprint through a strategic acquisition in South Korea, and accelerated progress towards mass production readiness at Fab2 in Malaysia. Recent Highl

      4/30/25 4:05:00 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Enovix Appoints Ryan Benton as Chief Financial Officer

      FREMONT, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX), a global high-performance battery company, announced the appointment of Ryan Benton as Chief Financial Officer (CFO). Mr. Benton brings over three decades of financial leadership experience. He previously held key roles at ASM International and served as CFO for multiple public companies including Silvaco and Exar Corporation. Enovix CEO Dr. Raj Talluri added, "Ryan's experience and transparent communication style make him an ideal leader for our finance organization and a strong voice in conveying our strategy to investors. As we get closer to achieving our top objective of commencing smartphone bat

      4/17/25 8:30:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Enovix To Acquire Korean Battery Cell Facility to Bolster Manufacturing

      FREMONT, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX), a global high-performance battery company, today announced the acquisition of battery cell manufacturing assets from SolarEdge, located in South Korea. The acquisition will expand the company's manufacturing footprint and help position Enovix to meet growing demand in the defense industry. The transaction is expected to close in April 2025, subject to the satisfaction of customary closing conditions. Enovix will be acquiring a battery cell manufacturing facility from SolarEdge that is approximately 330,000 square feet, as well as battery cell development and manufacturing equipment. The SolarEdge facilit

      4/3/25 8:30:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous